Literature DB >> 24835083

Key issues in addressing the comorbidity of attention deficit hyperactivity disorder and pediatric epilepsy.

Jay A Salpekar1, Gaurav Mishra2.   

Abstract

Attention deficit hyperactivity disorder (ADHD) is a common comorbidity of epilepsy encountered by clinicians. However, relatively little information is available to guide optimal diagnostic and treatment strategies. Differentiating ADHD from effects of epilepsy requires careful history taking and emphasis upon characteristic symptoms and course of illness. Rating scales for ADHD are well validated and may aid clinical management. Use of antiepileptic drugs may cause cognitive or behavioral side effects yet may improve behavior in some cases. Historically, clinicians have been hesitant to treat ADHD comorbidity for fear of lowering the seizure threshold. However, an aggregate of recent evidence now suggests that stimulants may be well tolerated and effective for ADHD comorbid with epilepsy. Studies that further clarify pathophysiology and treatment outcomes are needed in order to enhance clinical efficacy and quality of life for this population.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADHD; Diagnosis; Epilepsy; Pediatrics; Treatment

Mesh:

Substances:

Year:  2014        PMID: 24835083     DOI: 10.1016/j.yebeh.2014.04.021

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  9 in total

Review 1.  Autism spectrum disorder and epilepsy: Disorders with a shared biology.

Authors:  Bo Hoon Lee; Tristram Smith; Alex R Paciorkowski
Journal:  Epilepsy Behav       Date:  2015-04-19       Impact factor: 2.937

2.  Paying Attention to Quality of Life: Epilepsy and Attention Deficit Hyperactivity Disorder.

Authors:  Jay Salpekar
Journal:  Epilepsy Curr       Date:  2018 Jul-Aug       Impact factor: 7.500

3.  Lack of neuronal nitric oxide synthase results in attention deficit hyperactivity disorder-like behaviors in mice.

Authors:  Yudong Gao; Scott A Heldt
Journal:  Behav Neurosci       Date:  2015-02       Impact factor: 1.912

Review 4.  Epilepsy, cognition and behavior.

Authors:  Sheffali Gulati; Sangeetha Yoganathan; Biswaroop Chakrabarty
Journal:  Indian J Pediatr       Date:  2014-07-31       Impact factor: 1.967

Review 5.  Altered GABAergic Signaling in Brain Disease at Various Stages of Life.

Authors:  Yoo Sung Kim; Bo-Eun Yoon
Journal:  Exp Neurobiol       Date:  2017-05-19       Impact factor: 3.261

6.  Childhood epilepsy and ADHD comorbidity in an Indian tertiary medical center outpatient population.

Authors:  Anita Choudhary; Sheffali Gulati; Rajesh Sagar; Naveen Sankhyan; Kam Sripada
Journal:  Sci Rep       Date:  2018-02-08       Impact factor: 4.379

Review 7.  Inhibiting Epileptiform Activity in Cognitive Disorders: Possibilities for a Novel Therapeutic Approach.

Authors:  Andras Attila Horvath; Emoke Anna Csernus; Sara Lality; Rafal M Kaminski; Anita Kamondi
Journal:  Front Neurosci       Date:  2020-10-15       Impact factor: 4.677

8.  Low recognition of attention deficit hyperactivity disorder in adult patients admitted to the Epilepsy Monitoring Unit.

Authors:  Caitlynn Pham; Cayla Roy; Christine Tang; Atul Maheshwari
Journal:  Brain Behav       Date:  2022-07-27       Impact factor: 3.405

9.  Treatment of Children and Adolescents with Epilepsy with Atomoxetine.

Authors:  Kee Jeong Park; Hyunji Ahn; Mi-Sun Yum; Tae-Sung Ko; Hyo-Won Kim
Journal:  Psychiatry Investig       Date:  2020-04-17       Impact factor: 2.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.